Search - tctmd.com

Displaying 141 - 160 of 201

Sort: Relevancy | Date

News Industry News

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

June 16, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Industry News

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 14, 2014

News Industry News

Tryton Medical Announces Events at EuroPCR 2014 in Paris

May 12, 2014

News Industry News

Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the SENTINEL™ Cerebral Protection System

February 17, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Industry News

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

October 30, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

October 30, 2013

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

News Conference News TCT 2013

Memories of TCT from the Beginning: Martin B. Leon, MD

October 29, 2013

News Industry News

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

October 29, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Marvin L. Woodall

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Advertisement

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Tryton Medical Announces Events at EuroPCR 2014 in Paris

Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the SENTINEL™ Cerebral Protection System

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Two Trials to Assess TAVR in Moderate-Risk Patients

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

TCT Leadership Outlines the State of Intervention

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

Memories of TCT from the Beginning: Martin B. Leon, MD

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

Memories of TCT 1988 and Beyond: Marvin L. Woodall

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content